| REVOLUTION MEDICINES |
| USA |
| Gesundheit |
| US76155X1000 / A2PYWG |
| 42Z (Frankfurt) / RVMD (NASDAQ) |
| FRA:42Z, ETR:42Z, 42Z:GR, NASDAQ:RVMD |
| - |
| https://www.revmed.com/ |
|
Revolution Medicines Inc. is a clinical-stage precision oncology company focused on developing targeted cancer therapies. The company concentrates on inhibiting difficult-to-drug molecular targets within key cell growth and survival pathways, with pa..
>Volltext.. |
| 38841.75 Mio. EUR |
| 36438.63 Mio. EUR |
| - |
| -1378.26 Mio. EUR |
| -1514.54 Mio. EUR |
| -7.55 EUR |
| 1019.64 Mio. EUR |
| 698.42 Mio. EUR |
| -1047.53 Mio. EUR |
| 11.12 |
| - |
| -124.6% |
| - |
| - |
| - |
| - |
| REVOLUTION MEDICINES, REVOLUTION MED |
| 26.08.26 |
|
||||
|